CNOT6L and type 2 diabetes mellitus: Elevated expression of CNOT6L is notably observed in type 2 diabetes, where it contributes to diabetic complications, inflammation, and other physiological processes through the regulation of miRNA and related signaling pathways, ultimately resulting in a poor prognosis.